During the past decade, Centrum Osteoporozy i Chorób Kostno-Stawowych conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centrum Osteoporozy i Chorób Kostno-Stawowych" are "Rheumatoid Arthritis" (3 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Centrum Osteoporozy i Chorób Kostno-Stawowych" in a lesser frequency.

Most popular intervention types in "Centrum Osteoporozy i Chorób Kostno-Stawowych" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ARRY-438162, MEK inhibitor; oral" (1 trials), "ART621" (1 trials), "Apremilast 20 mg" (1 trials) and "Apremilast 30 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Osteoporozy i Chorób Kostno-Stawowych" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Osteoporozy i Chorób Kostno-Stawowych". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centrum Osteoporozy i Chorób Kostno-Stawowych, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Osteoporozy i Chorób Kostno-Stawowych, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".